Table 2. Insulin resistance of study groups.
|
|
Control |
PCO |
PCO+M |
PCO+P |
PCO+MP |
p-value |
|
FBG (mg/dL) |
122.5±9.46 |
134.7±7.31 |
212.2±43.29 |
125.7±7.03 |
109± 10.04 |
0.000* |
|
FINS (mU/L) |
3.1± 0.51 |
3.4± 0.65 |
4.1± 0.92 |
3.7± 0.61 |
4.3± 0.56 |
0.021** |
|
HOMA-IR |
0.9± 0.19 |
1.1± 0.23 |
2± 0.41 |
1.2± 0.24 |
1.2± 0.19 |
0.002* |
Data were presented as mean ± standard deviation. FBG: fasting blood glucose; FINS: fasting insulin;
HOMA-IR: homeostasis model assessment for insulin resistance index.
*Kruskal-Wallis; **ANOVA; Statistically significant if p-value is less than 0.05.